Anxiety

>

Latest News

MindMed Initiates Second Phase 3 Trial of Psychedelic MM120 for Generalized Anxiety Disorder / Image credit: ©Fukume/AdobeStock
MindMed Initiates Second Phase 3 Trial of Psychedelic MM120 for Generalized Anxiety Disorder

February 4th 2025

The first patient was dosed in the Panorama study assessing MM120 ODT, a form of LSD, for the treatment of GAD.

Minimal Distress Reported with Multi-Cancer Early Detection Testing: New Findings from PATHFINDER Trial / Image credit: ©Christoph Burgstedt/AdobeStock
Minimal Distress Reported with Multi-Cancer Early Detection Testing: New Findings from PATHFINDER Trial

January 14th 2025

Most US Adults Want Primary Care Physicians to Address Mental Health: Daily Dose/ image credit: ©New Africa/AdobeStock
Most US Adults Want Primary Care Physicians to Address Mental Health: Daily Dose

December 11th 2024

Three-quarters of US Adults want primary care providers to address mental health / image credit Tim Lash courtesy of West Health
Three-Quarters of US Adults Want to Be Asked About Mental Health in Primary Care Visits: New Survey

November 22nd 2024

Depression, Anxiety in Youth with Chronic Pain: Daily Dose / image credit: ©New Africa/AdobeStock
Depression, Anxiety in Youth with Chronic Pain: Daily Dose

October 15th 2024

Video Interviews

More News

© 2025 MJH Life Sciences

All rights reserved.